✎ Educationliveactive
Will the FDA approve MDMA for PTSD?
Before Jan 1, 2027
YES 19%NO 81%
24h volume
0
total volume
566.24
liquidity
$0
open interest
425.57
resolution
If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2027, then the market resolves to Yes.
closes Fri, 01 Jan 2027 04:59:00 GMT
engine call
PASS
fair 19% vs mkt 19%
edge +0.0pt · conf 20%
Neohood Engine is offline, so this shows the market-implied probability only. Configure the engine to get a calibrated fair-value estimate and edge.
key drivers
- Market-implied price
- Liquidity & volume
what would make it wrong
- No independent estimate available
Engine offline — showing market-implied prices only.
research, not financial advice · the Neohood Engine can be wrong · verify resolution terms before trading